NCT01523652View on ClinicalTrials.gov

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2007

Study Completion Date

November 30, 2008

Conditions
Genital Diseases, FemaleOvarian NeoplasmsUrogenital Neoplasms
Trial Locations (1)

Unknown

ASO Ordine Mauriziano, Turin

All Listed Sponsors
collaborator

University of Turin, Italy

OTHER

lead

Azienda Ospedaliera San Giovanni Battista

OTHER

NCT01523652 - Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients | Biotech Hunter | Biotech Hunter